For the past couple of years, cannabidiol (“CBD”) has held the world’s attention. Extracted from industrial hemp, a nonpsychoactive variety of cannabis, CBD is brimming with potent medicinal properties. Anecdotal evidence and preliminary research have found it effective against a host of medical conditions including anxiety, insomnia, post-traumatic stress disorder (“PTSD”) and pain.
According to a team of researchers from Italy and the United States, cannabidiol may also offer relief against scalp inflammation. Also known as scalp dermatitis, inflammation of the scalp usually results in flaky, itchy and painful patches. It is often caused by scalp psoriasis and seborrheic dermatitis. Dr. Shani Francis, a board-certified dermatologist who specializes in hair loss and the chief wellness officer of Ashira Dermatology, says that “scalp dermatitis is a very broad condition, and it has multiple diagnoses which are very common, as well as some rare ones.”
Save for a few instances, scalp inflammation isn’t a serious condition, and it can usually be treated with either topical treatments or over-the-counter medications. When researchers from Italy and the United States recently teamed up to explore the efficacy of cannabis-based shampoos on patients who suffer from scalp inflammation caused by scalp psoriasis or seborrheic dermatitis, the results were encouraging. The team found that cannabidiol has potent anti-inflammatory properties, making it a suitable treatment against a condition caused by inflammation, at least on paper.
They evaluated the “efficacy of a shampoo containing 0.075% broad-spectrum cannabidiol in 50 subjects with mild to moderate scalp psoriasis or seborrheic dermatitis,” the study authors note. At the end of the study, the researchers found that the CBD shampoo provided noticeable relief to study participants after only two weeks of use.
The researchers measured inflammation by evaluating how dense the twisted/glomerular or arborizing vessels were. They relied on trichoscopy using a six-point scale at baseline and day 14. Several symptoms, including itching or burning sensations, erythema/scaling, overall tolerability, as well as subject satisfaction were evaluated.
New York dermatologist Matthew Lin, MD, states that the endocannabinoid system works with CBD to reduce the symptoms of scalp inflammation. It acts on the cannabinoid receptors and reduces what are known as inflammatory cytokines within the scalp. Using a CBD shampoo could improve eczema, dandruff, and seborrheic dermatitis as well as an itchy, flaky scalp.
This lines up with what the team of researchers concluded at the end of the study. Changing the current shampooing practices and taking up a shampoo containing CBD can significantly reduce both the severity and the symptoms of scalp inflammation in approximately two weeks, with the added bonus of high tolerability and treatment satisfaction in people with mild or moderate scalp psoriasis or even seborrheic dermatitis.”
Sugarmade Inc. (OTCQB: SGMD) is a company you should watch in the cannabis sector. The firm specializes in offering delivery services to cannabis businesses, and SGMD has recently ramped up its plans to start marijuana cultivation.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
